nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR5—hindbrain—obesity	0.0294	0.159	CbGeAlD
Pasireotide—SSTR3—hindbrain—obesity	0.0282	0.152	CbGeAlD
Pasireotide—SSTR1—hindbrain—obesity	0.0223	0.12	CbGeAlD
Pasireotide—SSTR2—hindbrain—obesity	0.0189	0.102	CbGeAlD
Pasireotide—SSTR5—pituitary gland—obesity	0.0122	0.0657	CbGeAlD
Pasireotide—SSTR3—pituitary gland—obesity	0.0117	0.063	CbGeAlD
Pasireotide—Sinus bradycardia—Cimetidine—obesity	0.0107	0.0381	CcSEcCtD
Pasireotide—SSTR5—endocrine gland—obesity	0.00943	0.0509	CbGeAlD
Pasireotide—SSTR1—pituitary gland—obesity	0.00923	0.0498	CbGeAlD
Pasireotide—SSTR3—endocrine gland—obesity	0.00904	0.0488	CbGeAlD
Pasireotide—SSTR2—pituitary gland—obesity	0.00784	0.0424	CbGeAlD
Pasireotide—SSTR2—digestive system—obesity	0.00735	0.0397	CbGeAlD
Pasireotide—SSTR1—endocrine gland—obesity	0.00715	0.0386	CbGeAlD
Pasireotide—SSTR1—liver—obesity	0.00644	0.0348	CbGeAlD
Pasireotide—SSTR2—endocrine gland—obesity	0.00608	0.0328	CbGeAlD
Pasireotide—Abdominal pain upper—Phendimetrazine—obesity	0.00513	0.0183	CcSEcCtD
Pasireotide—Cholelithiasis—Orlistat—obesity	0.00465	0.0166	CcSEcCtD
Pasireotide—Cholelithiasis—Sibutramine—obesity	0.0045	0.016	CcSEcCtD
Pasireotide—Prothrombin level increased—Topiramate—obesity	0.00379	0.0135	CcSEcCtD
Pasireotide—Gamma-glutamyltransferase increased—Sibutramine—obesity	0.0034	0.0121	CcSEcCtD
Pasireotide—Sinus bradycardia—Topiramate—obesity	0.00317	0.0113	CcSEcCtD
Pasireotide—Hypercholesterolaemia—Sibutramine—obesity	0.00296	0.0106	CcSEcCtD
Pasireotide—Insomnia—Methamphetamine—obesity	0.00284	0.0101	CcSEcCtD
Pasireotide—Insomnia—Benzphetamine—obesity	0.00274	0.00977	CcSEcCtD
Pasireotide—Constipation—Methamphetamine—obesity	0.00269	0.00958	CcSEcCtD
Pasireotide—Decreased appetite—Benzphetamine—obesity	0.00264	0.00939	CcSEcCtD
Pasireotide—Hypercholesterolaemia—Bupropion—obesity	0.00258	0.0092	CcSEcCtD
Pasireotide—Insomnia—Phendimetrazine—obesity	0.0025	0.00891	CcSEcCtD
Pasireotide—Anxiety—Phenylpropanolamine—obesity	0.00245	0.00875	CcSEcCtD
Pasireotide—Alopecia—Diethylpropion—obesity	0.00244	0.00871	CcSEcCtD
Pasireotide—Diabetes mellitus—Orlistat—obesity	0.00241	0.00861	CcSEcCtD
Pasireotide—Decreased appetite—Phendimetrazine—obesity	0.0024	0.00856	CcSEcCtD
Pasireotide—Hypertension—Phentermine—obesity	0.00239	0.00852	CcSEcCtD
Pasireotide—Constipation—Phendimetrazine—obesity	0.00236	0.00842	CcSEcCtD
Pasireotide—Diabetes mellitus—Sibutramine—obesity	0.00234	0.00833	CcSEcCtD
Pasireotide—Alopecia—Cimetidine—obesity	0.00233	0.00829	CcSEcCtD
Pasireotide—Hypotension—Phenylpropanolamine—obesity	0.00221	0.00786	CcSEcCtD
Pasireotide—Abdominal pain—Phendimetrazine—obesity	0.00218	0.00779	CcSEcCtD
Pasireotide—Hypoglycaemia—Orlistat—obesity	0.00215	0.00767	CcSEcCtD
Pasireotide—Diarrhoea—Methamphetamine—obesity	0.00215	0.00767	CcSEcCtD
Pasireotide—Insomnia—Phenylpropanolamine—obesity	0.00213	0.00761	CcSEcCtD
Pasireotide—Hypoglycaemia—Sibutramine—obesity	0.00208	0.00742	CcSEcCtD
Pasireotide—Dizziness—Methamphetamine—obesity	0.00208	0.00741	CcSEcCtD
Pasireotide—Diarrhoea—Benzphetamine—obesity	0.00207	0.00739	CcSEcCtD
Pasireotide—Myalgia—Diethylpropion—obesity	0.00205	0.00731	CcSEcCtD
Pasireotide—Insomnia—Phentermine—obesity	0.00204	0.00728	CcSEcCtD
Pasireotide—Anxiety—Diethylpropion—obesity	0.00204	0.00728	CcSEcCtD
Pasireotide—Pain in extremity—Sibutramine—obesity	0.00203	0.00724	CcSEcCtD
Pasireotide—Constipation—Phenylpropanolamine—obesity	0.00202	0.00719	CcSEcCtD
Pasireotide—Dizziness—Benzphetamine—obesity	0.002	0.00715	CcSEcCtD
Pasireotide—Headache—Methamphetamine—obesity	0.00197	0.00702	CcSEcCtD
Pasireotide—Myalgia—Cimetidine—obesity	0.00195	0.00695	CcSEcCtD
Pasireotide—Arthralgia—Cimetidine—obesity	0.00195	0.00695	CcSEcCtD
Pasireotide—Fatigue—Phentermine—obesity	0.00195	0.00694	CcSEcCtD
Pasireotide—Anxiety—Cimetidine—obesity	0.00194	0.00693	CcSEcCtD
Pasireotide—Constipation—Phentermine—obesity	0.00193	0.00688	CcSEcCtD
Pasireotide—Dry skin—Orlistat—obesity	0.00193	0.00686	CcSEcCtD
Pasireotide—Abdominal pain upper—Orlistat—obesity	0.00192	0.00684	CcSEcCtD
Pasireotide—Hypokalaemia—Orlistat—obesity	0.00191	0.00681	CcSEcCtD
Pasireotide—Headache—Benzphetamine—obesity	0.0019	0.00677	CcSEcCtD
Pasireotide—Diarrhoea—Phendimetrazine—obesity	0.00189	0.00674	CcSEcCtD
Pasireotide—Gamma-glutamyltransferase increased—Topiramate—obesity	0.00189	0.00674	CcSEcCtD
Pasireotide—Dry skin—Sibutramine—obesity	0.00186	0.00664	CcSEcCtD
Pasireotide—Hypokalaemia—Sibutramine—obesity	0.00185	0.00659	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Sibutramine—obesity	0.00183	0.00652	CcSEcCtD
Pasireotide—Abdominal distension—Orlistat—obesity	0.00183	0.00651	CcSEcCtD
Pasireotide—Dizziness—Phendimetrazine—obesity	0.00183	0.00651	CcSEcCtD
Pasireotide—Hypoglycaemia—Bupropion—obesity	0.00182	0.00647	CcSEcCtD
Pasireotide—Influenza—Orlistat—obesity	0.00182	0.00647	CcSEcCtD
Pasireotide—Nausea—Benzphetamine—obesity	0.0018	0.00642	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Sibutramine—obesity	0.00179	0.00639	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Diethylpropion—obesity	0.00179	0.00638	CcSEcCtD
Pasireotide—Abdominal pain—Phentermine—obesity	0.00179	0.00636	CcSEcCtD
Pasireotide—Insomnia—Diethylpropion—obesity	0.00178	0.00633	CcSEcCtD
Pasireotide—Pain in extremity—Bupropion—obesity	0.00177	0.00632	CcSEcCtD
Pasireotide—Abdominal distension—Sibutramine—obesity	0.00177	0.0063	CcSEcCtD
Pasireotide—Influenza—Sibutramine—obesity	0.00176	0.00626	CcSEcCtD
Pasireotide—Headache—Phendimetrazine—obesity	0.00173	0.00617	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Cimetidine—obesity	0.0017	0.00607	CcSEcCtD
Pasireotide—Constipation—Diethylpropion—obesity	0.00168	0.00599	CcSEcCtD
Pasireotide—Nausea—Phendimetrazine—obesity	0.00164	0.00585	CcSEcCtD
Pasireotide—Dry skin—Bupropion—obesity	0.00162	0.00579	CcSEcCtD
Pasireotide—Asthenia—Phentermine—obesity	0.00162	0.00578	CcSEcCtD
Pasireotide—Abdominal pain upper—Bupropion—obesity	0.00162	0.00577	CcSEcCtD
Pasireotide—Fatigue—Cimetidine—obesity	0.00161	0.00575	CcSEcCtD
Pasireotide—Constipation—Cimetidine—obesity	0.0016	0.0057	CcSEcCtD
Pasireotide—Hyperglycaemia—Sibutramine—obesity	0.00158	0.00565	CcSEcCtD
Pasireotide—Nasopharyngitis—Bupropion—obesity	0.00158	0.00565	CcSEcCtD
Pasireotide—Dizziness—Phenylpropanolamine—obesity	0.00156	0.00556	CcSEcCtD
Pasireotide—Diarrhoea—Phentermine—obesity	0.00155	0.00551	CcSEcCtD
Pasireotide—Abdominal distension—Bupropion—obesity	0.00154	0.0055	CcSEcCtD
Pasireotide—Influenza—Bupropion—obesity	0.00153	0.00546	CcSEcCtD
Pasireotide—Vomiting—Phenylpropanolamine—obesity	0.0015	0.00535	CcSEcCtD
Pasireotide—Dizziness—Phentermine—obesity	0.00149	0.00532	CcSEcCtD
Pasireotide—Vomiting—Phentermine—obesity	0.00144	0.00512	CcSEcCtD
Pasireotide—Oedema peripheral—Orlistat—obesity	0.00143	0.0051	CcSEcCtD
Pasireotide—Headache—Phentermine—obesity	0.00142	0.00504	CcSEcCtD
Pasireotide—Nausea—Phenylpropanolamine—obesity	0.0014	0.005	CcSEcCtD
Pasireotide—Oedema peripheral—Sibutramine—obesity	0.00139	0.00494	CcSEcCtD
Pasireotide—Hyperglycaemia—Bupropion—obesity	0.00138	0.00492	CcSEcCtD
Pasireotide—Diarrhoea—Diethylpropion—obesity	0.00134	0.00479	CcSEcCtD
Pasireotide—Nausea—Phentermine—obesity	0.00134	0.00478	CcSEcCtD
Pasireotide—Asthenia—Cimetidine—obesity	0.00134	0.00478	CcSEcCtD
Pasireotide—Dizziness—Diethylpropion—obesity	0.0013	0.00463	CcSEcCtD
Pasireotide—Diabetes mellitus—Topiramate—obesity	0.0013	0.00463	CcSEcCtD
Pasireotide—Alopecia—Orlistat—obesity	0.00128	0.00458	CcSEcCtD
Pasireotide—Diarrhoea—Cimetidine—obesity	0.00128	0.00456	CcSEcCtD
Pasireotide—Vomiting—Diethylpropion—obesity	0.00125	0.00445	CcSEcCtD
Pasireotide—Alopecia—Sibutramine—obesity	0.00124	0.00443	CcSEcCtD
Pasireotide—Dizziness—Cimetidine—obesity	0.00124	0.00441	CcSEcCtD
Pasireotide—Headache—Diethylpropion—obesity	0.00123	0.00439	CcSEcCtD
Pasireotide—Back pain—Orlistat—obesity	0.00122	0.00436	CcSEcCtD
Pasireotide—Oedema peripheral—Bupropion—obesity	0.00121	0.0043	CcSEcCtD
Pasireotide—Vomiting—Cimetidine—obesity	0.00119	0.00424	CcSEcCtD
Pasireotide—Back pain—Sibutramine—obesity	0.00118	0.00422	CcSEcCtD
Pasireotide—Headache—Cimetidine—obesity	0.00117	0.00417	CcSEcCtD
Pasireotide—Nausea—Diethylpropion—obesity	0.00117	0.00416	CcSEcCtD
Pasireotide—Hypoglycaemia—Topiramate—obesity	0.00116	0.00412	CcSEcCtD
Pasireotide—Vertigo—Orlistat—obesity	0.00114	0.00405	CcSEcCtD
Pasireotide—Anaemia—Sibutramine—obesity	0.00113	0.00403	CcSEcCtD
Pasireotide—Pain in extremity—Topiramate—obesity	0.00113	0.00402	CcSEcCtD
Pasireotide—Nausea—Cimetidine—obesity	0.00111	0.00396	CcSEcCtD
Pasireotide—Vertigo—Sibutramine—obesity	0.0011	0.00392	CcSEcCtD
Pasireotide—Alopecia—Bupropion—obesity	0.00108	0.00386	CcSEcCtD
Pasireotide—Myalgia—Orlistat—obesity	0.00108	0.00384	CcSEcCtD
Pasireotide—Anxiety—Orlistat—obesity	0.00107	0.00382	CcSEcCtD
Pasireotide—Hypertension—Sibutramine—obesity	0.00106	0.00377	CcSEcCtD
Pasireotide—Arthralgia—Sibutramine—obesity	0.00104	0.00371	CcSEcCtD
Pasireotide—Myalgia—Sibutramine—obesity	0.00104	0.00371	CcSEcCtD
Pasireotide—Anxiety—Sibutramine—obesity	0.00104	0.0037	CcSEcCtD
Pasireotide—Back pain—Bupropion—obesity	0.00103	0.00368	CcSEcCtD
Pasireotide—Abdominal pain upper—Topiramate—obesity	0.00103	0.00368	CcSEcCtD
Pasireotide—Hypokalaemia—Topiramate—obesity	0.00103	0.00366	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Topiramate—obesity	0.00102	0.00362	CcSEcCtD
Pasireotide—Nasopharyngitis—Topiramate—obesity	0.00101	0.0036	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Topiramate—obesity	0.000996	0.00355	CcSEcCtD
Pasireotide—Anaemia—Bupropion—obesity	0.000986	0.00352	CcSEcCtD
Pasireotide—Abdominal distension—Topiramate—obesity	0.000982	0.0035	CcSEcCtD
Pasireotide—Vertigo—Bupropion—obesity	0.000959	0.00342	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Orlistat—obesity	0.00094	0.00335	CcSEcCtD
Pasireotide—Insomnia—Orlistat—obesity	0.000934	0.00333	CcSEcCtD
Pasireotide—Hypotension—Sibutramine—obesity	0.000934	0.00333	CcSEcCtD
Pasireotide—Hypertension—Bupropion—obesity	0.000921	0.00328	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Sibutramine—obesity	0.00091	0.00324	CcSEcCtD
Pasireotide—Arthralgia—Bupropion—obesity	0.000909	0.00324	CcSEcCtD
Pasireotide—Myalgia—Bupropion—obesity	0.000909	0.00324	CcSEcCtD
Pasireotide—Anxiety—Bupropion—obesity	0.000905	0.00323	CcSEcCtD
Pasireotide—Insomnia—Sibutramine—obesity	0.000904	0.00322	CcSEcCtD
Pasireotide—Decreased appetite—Orlistat—obesity	0.000897	0.0032	CcSEcCtD
Pasireotide—Fatigue—Orlistat—obesity	0.00089	0.00317	CcSEcCtD
Pasireotide—Hyperglycaemia—Topiramate—obesity	0.00088	0.00314	CcSEcCtD
Pasireotide—Decreased appetite—Sibutramine—obesity	0.000868	0.0031	CcSEcCtD
Pasireotide—Constipation—Sibutramine—obesity	0.000854	0.00304	CcSEcCtD
Pasireotide—Gastrointestinal pain—Orlistat—obesity	0.000844	0.00301	CcSEcCtD
Pasireotide—Gastrointestinal pain—Sibutramine—obesity	0.000817	0.00291	CcSEcCtD
Pasireotide—Abdominal pain—Orlistat—obesity	0.000816	0.00291	CcSEcCtD
Pasireotide—Hypotension—Bupropion—obesity	0.000814	0.0029	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Bupropion—obesity	0.000793	0.00283	CcSEcCtD
Pasireotide—Abdominal pain—Sibutramine—obesity	0.00079	0.00281	CcSEcCtD
Pasireotide—Insomnia—Bupropion—obesity	0.000788	0.00281	CcSEcCtD
Pasireotide—Oedema peripheral—Topiramate—obesity	0.000769	0.00274	CcSEcCtD
Pasireotide—Decreased appetite—Bupropion—obesity	0.000757	0.0027	CcSEcCtD
Pasireotide—Fatigue—Bupropion—obesity	0.000751	0.00268	CcSEcCtD
Pasireotide—Constipation—Bupropion—obesity	0.000745	0.00265	CcSEcCtD
Pasireotide—Asthenia—Orlistat—obesity	0.000741	0.00264	CcSEcCtD
Pasireotide—Pruritus—Orlistat—obesity	0.00073	0.0026	CcSEcCtD
Pasireotide—Asthenia—Sibutramine—obesity	0.000717	0.00255	CcSEcCtD
Pasireotide—Gastrointestinal pain—Bupropion—obesity	0.000712	0.00254	CcSEcCtD
Pasireotide—Pruritus—Sibutramine—obesity	0.000707	0.00252	CcSEcCtD
Pasireotide—Diarrhoea—Orlistat—obesity	0.000706	0.00252	CcSEcCtD
Pasireotide—Alopecia—Topiramate—obesity	0.00069	0.00246	CcSEcCtD
Pasireotide—Abdominal pain—Bupropion—obesity	0.000688	0.00245	CcSEcCtD
Pasireotide—Diarrhoea—Sibutramine—obesity	0.000684	0.00244	CcSEcCtD
Pasireotide—Dizziness—Orlistat—obesity	0.000683	0.00243	CcSEcCtD
Pasireotide—Dizziness—Sibutramine—obesity	0.000661	0.00235	CcSEcCtD
Pasireotide—Back pain—Topiramate—obesity	0.000658	0.00234	CcSEcCtD
Pasireotide—Vomiting—Orlistat—obesity	0.000656	0.00234	CcSEcCtD
Pasireotide—Headache—Orlistat—obesity	0.000647	0.0023	CcSEcCtD
Pasireotide—Vomiting—Sibutramine—obesity	0.000635	0.00226	CcSEcCtD
Pasireotide—Anaemia—Topiramate—obesity	0.000628	0.00224	CcSEcCtD
Pasireotide—Headache—Sibutramine—obesity	0.000626	0.00223	CcSEcCtD
Pasireotide—Asthenia—Bupropion—obesity	0.000625	0.00223	CcSEcCtD
Pasireotide—Pruritus—Bupropion—obesity	0.000616	0.0022	CcSEcCtD
Pasireotide—Nausea—Orlistat—obesity	0.000613	0.00219	CcSEcCtD
Pasireotide—Vertigo—Topiramate—obesity	0.000611	0.00218	CcSEcCtD
Pasireotide—Diarrhoea—Bupropion—obesity	0.000596	0.00212	CcSEcCtD
Pasireotide—Nausea—Sibutramine—obesity	0.000593	0.00212	CcSEcCtD
Pasireotide—Hypertension—Topiramate—obesity	0.000587	0.00209	CcSEcCtD
Pasireotide—Arthralgia—Topiramate—obesity	0.000579	0.00206	CcSEcCtD
Pasireotide—Myalgia—Topiramate—obesity	0.000579	0.00206	CcSEcCtD
Pasireotide—Anxiety—Topiramate—obesity	0.000577	0.00206	CcSEcCtD
Pasireotide—Dizziness—Bupropion—obesity	0.000576	0.00205	CcSEcCtD
Pasireotide—Vomiting—Bupropion—obesity	0.000554	0.00197	CcSEcCtD
Pasireotide—Headache—Bupropion—obesity	0.000546	0.00194	CcSEcCtD
Pasireotide—Hypotension—Topiramate—obesity	0.000518	0.00185	CcSEcCtD
Pasireotide—Nausea—Bupropion—obesity	0.000517	0.00184	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Topiramate—obesity	0.000506	0.0018	CcSEcCtD
Pasireotide—Insomnia—Topiramate—obesity	0.000502	0.00179	CcSEcCtD
Pasireotide—Decreased appetite—Topiramate—obesity	0.000482	0.00172	CcSEcCtD
Pasireotide—Fatigue—Topiramate—obesity	0.000478	0.00171	CcSEcCtD
Pasireotide—Constipation—Topiramate—obesity	0.000474	0.00169	CcSEcCtD
Pasireotide—Gastrointestinal pain—Topiramate—obesity	0.000454	0.00162	CcSEcCtD
Pasireotide—Abdominal pain—Topiramate—obesity	0.000439	0.00156	CcSEcCtD
Pasireotide—Asthenia—Topiramate—obesity	0.000398	0.00142	CcSEcCtD
Pasireotide—Pruritus—Topiramate—obesity	0.000393	0.0014	CcSEcCtD
Pasireotide—Diarrhoea—Topiramate—obesity	0.00038	0.00135	CcSEcCtD
Pasireotide—Dizziness—Topiramate—obesity	0.000367	0.00131	CcSEcCtD
Pasireotide—Vomiting—Topiramate—obesity	0.000353	0.00126	CcSEcCtD
Pasireotide—Headache—Topiramate—obesity	0.000348	0.00124	CcSEcCtD
Pasireotide—Nausea—Topiramate—obesity	0.00033	0.00117	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—RHOA—obesity	5.84e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—GNAS—obesity	5.81e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3R1—obesity	5.78e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CD—obesity	5.73e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—POMC—obesity	5.73e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—GNB3—obesity	5.72e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—F2—obesity	5.71e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PRKCB—obesity	5.71e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APOB—obesity	5.69e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—TYK2—obesity	5.64e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—POMC—obesity	5.63e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CB—obesity	5.63e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CNR1—obesity	5.63e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IGF2—obesity	5.62e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PRL—obesity	5.62e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—RHOA—obesity	5.6e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—GNAS—obesity	5.57e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCL5—obesity	5.56e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3R1—obesity	5.54e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—STK11—obesity	5.54e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TCF7L2—obesity	5.53e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCL2—obesity	5.51e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AKT2—obesity	5.5e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—DRD2—obesity	5.49e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PLG—obesity	5.48e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—RHOA—obesity	5.47e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CG—obesity	5.46e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APOB—obesity	5.46e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—LPL—obesity	5.44e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTPN1—obesity	5.44e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GCG—obesity	5.44e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AKT2—obesity	5.42e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3R1—obesity	5.41e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FOXO1—obesity	5.4e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RPS6KB1—obesity	5.39e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FOXO3—obesity	5.34e-05	0.0001	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CB—obesity	5.33e-05	9.98e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ADRB2—obesity	5.33e-05	9.98e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL5—obesity	5.33e-05	9.98e-05	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CD—obesity	5.29e-05	9.9e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SOCS1—obesity	5.25e-05	9.83e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—LPL—obesity	5.21e-05	9.75e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CD—obesity	5.2e-05	9.74e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—POMC—obesity	5.2e-05	9.73e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SOCS3—obesity	5.19e-05	9.71e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PRL—obesity	5.19e-05	9.71e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FOXO1—obesity	5.17e-05	9.68e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RPS6KB1—obesity	5.16e-05	9.67e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CB—obesity	5.11e-05	9.57e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STK11—obesity	5.11e-05	9.57e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCL2—obesity	5.09e-05	9.52e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—GNB3—obesity	5.08e-05	9.5e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PLG—obesity	5.05e-05	9.46e-05	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—RHOA—obesity	5.05e-05	9.44e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PRKCD—obesity	5.01e-05	9.37e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—TYK2—obesity	5.01e-05	9.37e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AKT2—obesity	5e-05	9.35e-05	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CB—obesity	4.99e-05	9.35e-05	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3R1—obesity	4.99e-05	9.35e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IGF2—obesity	4.99e-05	9.33e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—RHOA—obesity	4.96e-05	9.29e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—GNAS—obesity	4.94e-05	9.25e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FOXO3—obesity	4.93e-05	9.23e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ADRB2—obesity	4.92e-05	9.21e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3R1—obesity	4.91e-05	9.2e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HTR2A—obesity	4.9e-05	9.17e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—C3—obesity	4.89e-05	9.16e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SOCS1—obesity	4.84e-05	9.07e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APOB—obesity	4.84e-05	9.06e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CD—obesity	4.8e-05	8.99e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PRKCD—obesity	4.8e-05	8.99e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SOCS3—obesity	4.79e-05	8.96e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL5—obesity	4.73e-05	8.85e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HTR2A—obesity	4.7e-05	8.8e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—C3—obesity	4.69e-05	8.78e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GNB3—obesity	4.68e-05	8.77e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IRS2—obesity	4.66e-05	8.72e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AGT—obesity	4.65e-05	8.7e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—LPL—obesity	4.62e-05	8.65e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—TYK2—obesity	4.62e-05	8.65e-05	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CB—obesity	4.61e-05	8.63e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IGF2—obesity	4.6e-05	8.61e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FOXO1—obesity	4.59e-05	8.59e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—RHOA—obesity	4.58e-05	8.58e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RPS6KB1—obesity	4.58e-05	8.57e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GNAS—obesity	4.56e-05	8.54e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—LEP—obesity	4.56e-05	8.53e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APOE—obesity	4.56e-05	8.53e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CB—obesity	4.54e-05	8.49e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3R1—obesity	4.53e-05	8.49e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CAV1—obesity	4.51e-05	8.45e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APOA1—obesity	4.5e-05	8.43e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APOB—obesity	4.47e-05	8.36e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IRS2—obesity	4.46e-05	8.36e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AGT—obesity	4.46e-05	8.35e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APOE—obesity	4.37e-05	8.18e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—LEP—obesity	4.37e-05	8.18e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCL5—obesity	4.36e-05	8.17e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ESR1—obesity	4.35e-05	8.14e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CAV1—obesity	4.33e-05	8.1e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APOA1—obesity	4.32e-05	8.08e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—F2—obesity	4.3e-05	8.04e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PRKCB—obesity	4.3e-05	8.04e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—LPL—obesity	4.27e-05	7.98e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PRKCD—obesity	4.26e-05	7.97e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BAD—obesity	4.25e-05	7.95e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FOXO1—obesity	4.23e-05	7.93e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RPS6KB1—obesity	4.23e-05	7.91e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CB—obesity	4.19e-05	7.83e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ESR1—obesity	4.17e-05	7.81e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HTR2A—obesity	4.17e-05	7.8e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—C3—obesity	4.16e-05	7.79e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—F2—obesity	4.12e-05	7.71e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PRKCB—obesity	4.12e-05	7.71e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CG—obesity	4.11e-05	7.7e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BAD—obesity	4.07e-05	7.62e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IRS1—obesity	4.06e-05	7.61e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IRS2—obesity	3.96e-05	7.41e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AGT—obesity	3.95e-05	7.4e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CG—obesity	3.94e-05	7.38e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PRKCD—obesity	3.93e-05	7.36e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—POMC—obesity	3.91e-05	7.33e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IRS1—obesity	3.9e-05	7.29e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—INS—obesity	3.89e-05	7.29e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—LEP—obesity	3.87e-05	7.25e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APOE—obesity	3.87e-05	7.25e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HTR2A—obesity	3.85e-05	7.2e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—C3—obesity	3.84e-05	7.19e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CAV1—obesity	3.84e-05	7.19e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCL2—obesity	3.83e-05	7.17e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APOA1—obesity	3.83e-05	7.17e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IGF1—obesity	3.76e-05	7.05e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AKT2—obesity	3.76e-05	7.04e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—POMC—obesity	3.75e-05	7.02e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—INS—obesity	3.73e-05	6.99e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ESR1—obesity	3.7e-05	6.92e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL2—obesity	3.67e-05	6.87e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IRS2—obesity	3.65e-05	6.84e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PRKCB—obesity	3.65e-05	6.84e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—F2—obesity	3.65e-05	6.84e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AGT—obesity	3.65e-05	6.83e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CD—obesity	3.61e-05	6.77e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BAD—obesity	3.61e-05	6.76e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IGF1—obesity	3.61e-05	6.76e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKT2—obesity	3.61e-05	6.75e-05	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CA—obesity	3.58e-05	6.7e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SERPINE1—obesity	3.58e-05	6.69e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—LEP—obesity	3.58e-05	6.69e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APOE—obesity	3.58e-05	6.69e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CAV1—obesity	3.54e-05	6.63e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APOA1—obesity	3.53e-05	6.62e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CG—obesity	3.5e-05	6.54e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TYK2—obesity	3.48e-05	6.51e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CD—obesity	3.47e-05	6.49e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IRS1—obesity	3.46e-05	6.47e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RHOA—obesity	3.45e-05	6.46e-05	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CA—obesity	3.43e-05	6.43e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SERPINE1—obesity	3.43e-05	6.42e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NOS3—obesity	3.41e-05	6.39e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3R1—obesity	3.41e-05	6.39e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ESR1—obesity	3.41e-05	6.39e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—F2—obesity	3.37e-05	6.31e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PRKCB—obesity	3.37e-05	6.31e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TYK2—obesity	3.33e-05	6.24e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BAD—obesity	3.33e-05	6.24e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—POMC—obesity	3.33e-05	6.23e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—INS—obesity	3.31e-05	6.2e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RHOA—obesity	3.31e-05	6.19e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3R1—obesity	3.27e-05	6.13e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NOS3—obesity	3.27e-05	6.13e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL2—obesity	3.26e-05	6.1e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CA—obesity	3.25e-05	6.09e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CG—obesity	3.23e-05	6.04e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IGF1—obesity	3.2e-05	5.99e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKT2—obesity	3.2e-05	5.99e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IRS1—obesity	3.19e-05	5.97e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MTOR—obesity	3.15e-05	5.9e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CB—obesity	3.15e-05	5.9e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CA—obesity	3.12e-05	5.84e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CD—obesity	3.07e-05	5.75e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—POMC—obesity	3.07e-05	5.75e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—INS—obesity	3.05e-05	5.72e-05	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CA—obesity	3.04e-05	5.7e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SERPINE1—obesity	3.04e-05	5.69e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CB—obesity	3.02e-05	5.65e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MTOR—obesity	3.02e-05	5.65e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCL2—obesity	3.01e-05	5.63e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TYK2—obesity	2.96e-05	5.53e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IGF1—obesity	2.95e-05	5.53e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKT2—obesity	2.95e-05	5.53e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RHOA—obesity	2.93e-05	5.49e-05	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—AKT1—obesity	2.92e-05	5.48e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3R1—obesity	2.9e-05	5.43e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NOS3—obesity	2.9e-05	5.43e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6—obesity	2.88e-05	5.39e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CD—obesity	2.84e-05	5.31e-05	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CA—obesity	2.81e-05	5.26e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SERPINE1—obesity	2.81e-05	5.25e-05	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—AKT1—obesity	2.8e-05	5.25e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CA—obesity	2.76e-05	5.18e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6—obesity	2.76e-05	5.17e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MMP9—obesity	2.74e-05	5.13e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TYK2—obesity	2.73e-05	5.11e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RHOA—obesity	2.71e-05	5.07e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MTOR—obesity	2.68e-05	5.01e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CB—obesity	2.68e-05	5.01e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3R1—obesity	2.68e-05	5.01e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NOS3—obesity	2.68e-05	5.01e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK8—obesity	2.66e-05	4.99e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AKT1—obesity	2.66e-05	4.97e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MMP9—obesity	2.63e-05	4.91e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK8—obesity	2.55e-05	4.78e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CA—obesity	2.55e-05	4.78e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—AKT1—obesity	2.55e-05	4.77e-05	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AKT1—obesity	2.49e-05	4.66e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CB—obesity	2.47e-05	4.63e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MTOR—obesity	2.47e-05	4.63e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6—obesity	2.45e-05	4.58e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—STAT3—obesity	2.43e-05	4.56e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—STAT3—obesity	2.33e-05	4.37e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MMP9—obesity	2.33e-05	4.36e-05	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AKT1—obesity	2.3e-05	4.3e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK8—obesity	2.26e-05	4.24e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MYC—obesity	2.26e-05	4.24e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6—obesity	2.26e-05	4.23e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AKT1—obesity	2.26e-05	4.23e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TGFB1—obesity	2.26e-05	4.23e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MYC—obesity	2.17e-05	4.06e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TGFB1—obesity	2.16e-05	4.05e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MMP9—obesity	2.15e-05	4.02e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK8—obesity	2.09e-05	3.91e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AKT1—obesity	2.08e-05	3.9e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—STAT3—obesity	2.07e-05	3.88e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MYC—obesity	1.92e-05	3.6e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CA—obesity	1.92e-05	3.6e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TGFB1—obesity	1.92e-05	3.59e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STAT3—obesity	1.91e-05	3.58e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CA—obesity	1.84e-05	3.45e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MYC—obesity	1.78e-05	3.32e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TGFB1—obesity	1.77e-05	3.32e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6—obesity	1.7e-05	3.18e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CA—obesity	1.63e-05	3.06e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6—obesity	1.63e-05	3.05e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AKT1—obesity	1.57e-05	2.94e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CA—obesity	1.51e-05	2.82e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKT1—obesity	1.5e-05	2.82e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6—obesity	1.45e-05	2.71e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6—obesity	1.33e-05	2.5e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKT1—obesity	1.33e-05	2.5e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKT1—obesity	1.23e-05	2.3e-05	CbGpPWpGaD
